ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

CERE Cerevel Therapeutics Holdings Inc

42.645
-0.065 (-0.15%)
최종 업데이트: 00:29:18
15분 지연
기업명 주식 심볼 시장 주식 타입
Cerevel Therapeutics Holdings Inc CERE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.065 -0.15% 42.645 00:29:18
개장가 저가 고가 종가 전일 종가
42.73 42.645 42.86 42.71
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202419:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
28/02/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/02/202406:46EDGAR2Form 8-K - Current report
09/02/202423:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/02/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202422:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
24/01/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202407:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202407:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202421:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
18/01/202421:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
06/01/202407:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
03/01/202408:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
29/12/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202307:03EDGAR2Form 144 - Report of proposed sale of securities
22/12/202310:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202308:34EDGAR2Form 144 - Report of proposed sale of securities
12/12/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202307:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202320:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
08/12/202309:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202306:32EDGAR2Form 144 - Report of proposed sale of securities
08/12/202306:31EDGAR2Form 144 - Report of proposed sale of securities
07/12/202322:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202322:00EDGAR2Form 8-K - Current report
07/12/202320:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
07/12/202313:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
07/12/202306:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
06/12/202308:42EDGAR2Form 144 - Report of proposed sale of securities
29/11/202320:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
08/11/202320:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
01/11/202319:39EDGAR2Form 8-K - Current report
01/11/202319:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
19/10/202305:32EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202319:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
13/10/202305:19EDGAR2Form 8-K - Current report
13/10/202305:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202311:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
12/10/202305:14EDGAR2Form 8-K - Current report
12/10/202305:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202305:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

최근 히스토리

Delayed Upgrade Clock